CND Life Sciences Partners with Soleo Health to Broaden the Awareness and Availability of CND’s Cutaneous Neurodiagnostic Tests

Collaboration Focuses on CND’s Groundbreaking Syn-One Test® that Aids in the Diagnosis of Parkinson’s Disease and Other Neurodegenerative Disorders PHOENIX and FRISCO, Texas , Nov. 3, 2022 /PRNewswire/ — CND Life Sciences (http://cndlifesciences.com), an innovative medical diagnostics…

Click here to view original post